Episode 80: Patients Need Checkpoint Inhibitor Education
Dec 06, 2019•33 min•Season 1Ep. 80
Episode description
This episode was supported by funding from Bristol-Myers Squibb Company.
ONS member Laura Wood, RN, MSN, OCN®, renal cancer research coordinator at the Cleveland Clinic Cancer Center in Ohio and member of the Cleveland ONS Chapter, joins Chris Pirschel, ONS staff writer/producer, to discuss patient education for immune checkpoint inhibitors, overcoming communication barriers, and the best strategies for successful patient education.
Music Credit: "Fireflies and Stardust" Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0
Episode Notes
Check out these resources from today's episode:
- The NCPD activity for this episode has expired, but you can still earn NCPD through many other Oncology Nursing Podcast episodes. Find a full list of opportunities.
- Resources Are Available to Guide Management of Immunotherapy-Related Adverse Events
- Common Terminology Criteria for Adverse Events (CTCAE)
- Using CTCAE to Report Immunotherapy Adverse Events
- Immune Checkpoint Inhibitor Therapy: Key Principles When Educating Patients
- About Immunotherapy
- Management of Immunotherapy-Related Toxicities
- Society for Immunotherapy of Cancer
For the best experience, listen in Metacast app for iOS or Android
